991 - Single Center, Exploratory, Open-label Prospective Study Using the Minimally Invasive LysinDAIR Procedure (Lysin Administration During an Arthroscopic DAIR Procedure) in Patients with Suspected Relapsing Chronic Coagulase-Negative Staphylococci (CNS) Prosthetic Hip Infection (PHI)

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Presenting Author(s)

AC

Anne Conrad, n/a

Hospices Civils de Lyon
Lyon, Rhone-Alpes, France
CK

Camille Kolenda, n/a

Hospices Civils de Lyon
Lyon, Rhone-Alpes, France
fL

frederic Laurent, n/a

Prof.
Hospices Civils de Lyon
Lyon, Rhone-Alpes, France
AS

Axel Schmidt, n/a

Hospices Civils de Lyon
Lyon, Rhone-Alpes, France
cara cassino, n/a

Chief Medical Officer and Executive Vice President of Research and Development
Contrafect Corporation
New-York, New York, United States
sL

sebastien Lustig, n/a

Hospices Civils de Lyon
Lyon, Rhone-Alpes, France
CB

Cécile Batailler, n/a

Dr.
Hospices Civils de Lyon
Lyon, Rhone-Alpes, France